We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+2.38%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$16.4B
AUM Growth
+$994M
(+6.5%)
Cap. Flow
-$2.67B
Cap. Flow
% of AUM
-16.31%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
653
New
51
Increased
212
Reduced
120
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$65.8M |
| 2 |
Cboe Global Markets
CBOE
|
+$65.4M |
| 3 |
Elevance Health
ELV
|
+$49.3M |
| 4 |
Mohawk Industries
MHK
|
+$49.2M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$44.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANTX
Anthem, Inc.
ANTX
|
+$77.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$69.6M |
| 3 |
AbbVie
ABBV
|
+$35.3M |
| 4 |
FRC
First Republic Bank
FRC
|
+$31.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.47% |
| 2 | Technology | 8.96% |
| 3 | Healthcare | 8.59% |
| 4 | Communication Services | 6.53% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Philip Morris
PM
$301B
| $95.6M | 0.58% |
1,184,123
+356,025
| +43% | +$30.2M |
|
27
McDonald's
MCD
$188B
| $94.3M | 0.58% |
601,795
+90,357
| +18% | +$14.7M |
|
28
Walt Disney
DIS
$165B
| $92.2M | 0.56% |
879,402
-28,872
| -3% | -$2.95M |
|
|
CCI.PRA
29
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $86.2M | 0.53% |
81,680
+17
| +0% | +$18K |
|
30
Mastercard
MA
$477B
| $84M | 0.51% |
427,485
+4,132
| +1% | +$777K |
|
31
Citigroup
C
$222B
| $80.1M | 0.49% |
1,196,611
+94,670
| +9% | +$6.52M |
|
32
Boeing
BA
$165B
| $78.9M | 0.48% |
235,067
+77,023
| +49% | +$26.5M |
|
33
SLB Ltd
SLB
$78.4B
| $78.3M | 0.48% |
1,167,417
+59,225
| +5% | +$4.07M |
|
|
ALXN
34
DELISTED
Alexion Pharmaceuticals
ALXN
| $77.3M | 0.47% |
622,746
+27,168
| +5% | +$3.18M |
|
35
Pfizer
PFE
$140B
| $76.8M | 0.47% |
2,230,394
+107,767
| +5% | +$3.68M |
|
|
NEE.PRR
36
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $76.6M | 0.47% |
1,341,628
+1,515
| +0.1% | +$86K |
|
37
Coca-Cola
KO
$354B
| $75M | 0.46% |
1,710,864
-14,621
| -0.8% | -$631K |
|
38
Labcorp
LH
$24.3B
| $72M | 0.44% |
467,042
+72,453
| +18% | +$10.9M |
|
39
Humana
HUM
$46.7B
| $71.7M | 0.44% |
240,973
-8,701
| -3% | -$2.55M |
|
40
Intercontinental Exchange
ICE
$82.4B
| $71.4M | 0.44% |
970,851
+128,277
| +15% | +$9.34M |
|
|
41
AbbVie
ABBV
$458B
| $70.9M | 0.43% |
765,314
-361,697
| -32% | -$35.3M |
|
42
Halliburton
HAL
$27.9B
| $69.1M | 0.42% |
1,534,020
+264,318
| +21% | +$13.2M |
|
|
MRSH
43
Marsh
MRSH
$86.3B
| $67.1M | 0.41% |
818,236
+96,699
| +13% | +$7.89M |
|
44
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $66.8M | 0.41% |
53,013
-142
| -0.3% | -$181K |
|
45
Comcast
CMCSA
$79.7B
| $65.2M | 0.4% |
1,986,029
-316,698
| -14% | -$10.3M |
|
46
Cisco
CSCO
$450B
| $64.9M | 0.4% |
1,507,124
+138,054
| +10% | +$6.03M |
|
|
BDXA
47
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $64.6M | 0.4% |
1,045,129
+315
| +0% | +$18.8K |
|
48
Procter & Gamble
PG
$343B
| $64.6M | 0.4% |
828,026
-47,490
| -5% | -$3.57M |
|
|
49
Cboe Global Markets
CBOE
$29.8B
| $64.5M | 0.39% |
+619,398
| New | +$65.4M |
|
|
ETFC
50
DELISTED
E*Trade Financial Corporation
ETFC
| $64.2M | 0.39% |
1,049,985
-329,595
| -24% | -$20.4M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Calamos Advisors held 653 positions worth $16.4B, up 6.5% from $15.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $2.67B in Q2 2018, closing 58 positions and reducing 120 holdings. Its most notable exit was Anthem, Inc., an estimated $77.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Cboe Global Markets worth $64.5M.
- Calamos Advisors's largest Q2 2018 buy was Cboe Global Markets: 619,398 shares worth $64.5M.
- Calamos Advisors added most to Goldman Sachs in Q2 2018, an estimated $65.8M increase.
- Calamos Advisors's biggest Q2 2018 reduction was Allergan plc, cutting an estimated $69.6M.
- Calamos Advisors fully exited Anthem, Inc. in Q2 2018, selling an estimated $77.5M.
- Calamos Advisors's ten largest holdings make up 20% of its $16.4B portfolio in Q2 2018.
- Calamos Advisors opened 51 new positions and closed 58 in Q2 2018.
- Calamos Advisors's portfolio value rose 6.5% quarter-over-quarter to $16.4B.
Based on Calamos Advisors's 13F filing for Q2 2018, filed 17 Jul 2018.